|
|
||||||||
CUTTING EDGE |


*
Department of Medicine and
Howard Hughes Medical Institute, University of California, San Francisco, CA 94143
IL-2 gene transcription in T cells requires both TCR and costimulatory signals. IL-2 promoter activation in Jurkat T cells stimulated with superantigen presented by Raji B cells requires CD28 activation. The addition of rCTLA4Ig, which blocks CD28 binding to its ligand, to the cultures decreased IL-2 promoter activation by >80%. Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells (NFAT) or AP-1 reporters. Therefore, activation of NFAT and AP-1 is insufficient for IL-2 promoter activation. In contrast, an RE/AP reporter was blocked by CTLA4Ig by >90%. Thus, the requirement for CD28 in IL-2 promoter activation appears to be due to RE/AP and not the NFAT or AP-1 sites. In addition, these data suggest that transcriptional activation of RE/AP is not mediated by NFAT, because activation of a NFAT reporter is not affected by the addition of CTLA4Ig.
This article has been cited by other articles:
![]() |
B. Li, A. Samanta, X. Song, K. T. Iacono, P. Brennan, T. A. Chatila, G. Roncador, A. H. Banham, J. L. Riley, Q. Wang, et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease Int. Immunol., July 1, 2007; 19(7): 825 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Legarda-Addison and A. T. Ting Negative Regulation of TCR Signaling by NF-{kappa}B2/p100 J. Immunol., June 15, 2007; 178(12): 7767 - 7778. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Li, A. Samanta, X. Song, K. T. Iacono, K. Bembas, R. Tao, S. Basu, J. L. Riley, W. W. Hancock, Y. Shen, et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression PNAS, March 13, 2007; 104(11): 4571 - 4576. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Cismasiu, S. Ghanta, J. Duque, D. I. Albu, H.-M. Chen, R. Kasturi, and D. Avram BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes Blood, October 15, 2006; 108(8): 2695 - 2702. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Perchonock, M. C. Fernando, W. J. Quinn III, C. T. Nguyen, J. Sun, M. J. Shapiro, and V. S. Shapiro Negative Regulation of Interleukin-2 and p38 Mitogen-Activated Protein Kinase during T-Cell Activation by the Adaptor ALX. Mol. Cell. Biol., August 1, 2006; 26(16): 6005 - 6015. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xing, L. T. Donlin, R. H. Miller, and K. Alexandropoulos The Adapter Molecule Sin Regulates T-Cell-Receptor-Mediated Signal Transduction by Modulating Signaling Substrate Availability Mol. Cell. Biol., May 15, 2004; 24(10): 4581 - 4592. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Schubert, R. Q. Cron, A. M. Cleary, M. Brunner, A. Song, L.-S. Lu, P. Jullien, A. M. Krensky, and D. B. Lewis A T Cell-specific Enhancer of the Human CD40 Ligand Gene J. Biol. Chem., February 22, 2002; 277(9): 7386 - 7395. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Shapiro, M. N. Mollenauer, and A. Weiss Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression Blood, July 1, 2001; 98(1): 187 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gonzalez, C. Punzon, M. Gonzalez, and M. Fresno HIV-1 Tat Inhibits IL-2 Gene Transcription Through Qualitative and Quantitative Alterations of the Cooperative Rel/AP1 Complex Bound to the CD28RE/AP1 Composite Element of the IL-2 Promoter J. Immunol., April 1, 2001; 166(7): 4560 - 4569. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Michel, G. Mangino, G. Attal-Bonnefoy, L. Tuosto, A. Alcover, A. Roumier, D. Olive, and O. Acuto CD28 Utilizes Vav-1 to Enhance TCR-Proximal Signaling and NF-AT Activation J. Immunol., October 1, 2000; 165(7): 3820 - 3829. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Glimcher and K. M. Murphy Lineage commitment in the immune system: the T helper lymphocyte grows up Genes & Dev., July 15, 2000; 14(14): 1693 - 1711. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |